The Pennant Group, Inc.

The Pennant Group, Inc. (PNTG) Market Cap

The Pennant Group, Inc. has a market capitalization of $1.40B.

Price: $40.32

β–Ό -0.81 (-1.97%)

Market Cap: 1.40B

NASDAQ Β· time unavailable

CEO: Brent J. Guerisoli

Sector: Healthcare

Industry: Medical - Care Facilities

IPO Date: 2019-10-01

Website: https://www.pennantgroup.com

The Pennant Group, Inc. (PNTG) - Company Information

Market Cap: 1.40B|Sector: Healthcare

Company Profile

The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.

Analyst Sentiment

86%
Strong Buy

From 7 Active Polls

1Y Forecast: $44.33

β–² +9.9% Potential Upside

Consensus Target Metrics

Low Bound

$40

Median

$45

High Bound

$48

Average

$44

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$44.33
β–² +9.95% Upside
Low Target
$40.00
-1% Risk
Median Target
$45.00
12% Mid
High Target
$48.00
19% Max
Consensus
Buy
6 / 7 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

πŸ“Š Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,4021,0589758731,0318679091,081705
Enterprise Value ($M)1,8501,5061,4121,1731,3301,1951,1581,4531,055
Price to Earnings Ratio (P/E)45.3030.4828.1535.0335.5427.3439.0044.6330.79
Price/Earnings-to-Growth Ratio (PEG)β€”β€”1.078.067.722.468.596.314.08
Price to Sales Ratio (P/S)1.373.713.373.814.704.134.815.984.18
Price to Book Ratio (P/B)4.053.062.932.713.292.863.106.384.53
Price to Free Cash Flow Ratio (P/FCF)35.86-122.0169.8083.3844.18-37.3952.69159.3389.59
Enterprise Value to Sales (EV/Sales)β€”5.284.885.126.065.696.138.046.25
Enterprise Value to EBITDA (EV/EBITDA)30.82110.4770.9993.9894.9382.57104.50117.2595.62
Debt to Equity Ratio7.461.311.360.941.001.100.932.232.26

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ PENNANT GROUP INC (PNTG) β€” Investment Overview

🧩 Business Model Overview

Pennant Group provides behavioral health services through a network of clinical programs and facilities, delivering care across the treatment continuum for individuals with mental health and related needs. The value chain centers on (1) securing access to eligible patients through referral and payer channels, (2) operating licensed care settings and multidisciplinary clinical teams, and (3) converting clinical capacity into reimbursable treatment days/episodes.

Customer β€œstickiness” is driven less by contractual switching costs and more by continuity of care: stable care pathways, established clinical protocols, and established referral relationships for patient intake and treatment escalation. Over time, these factors create operational inertia that can be difficult for smaller entrants to replicate at scale.

πŸ’° Revenue Streams & Monetisation Model

Revenue is primarily derived from reimbursed behavioral health services, typically tied to utilization (treatment volume) and the patient mix across payers such as Medicaid and commercial insurance. Monetisation is operational: as clinical staffing, facility throughput, and documentation quality translate into billable care, revenue scales with utilization.

Margin structure is influenced by:

  • Staffing efficiency and labor costs: behavioral health services are personnel-intensive; clinical staffing ratios and wage inflation affect operating margins.
  • Reimbursement economics: payer rates, billing practices, authorization requirements, and denial management directly impact net realizations.
  • Utilization and occupancy: underutilized capacity compresses margins, while sustained throughput improves absorption of fixed overhead.

🧠 Competitive Advantages & Market Positioning

Pennant Group’s moat is best characterized as a blend of regulatory/operational barriers and intangibles from clinical delivery at scale.

  • Regulatory and licensing barriers (High Barriers to Entry): operating behavioral health programs requires facility compliance, clinical oversight, and ongoing regulatory scrutiny. Establishing and maintaining these capabilities is time-consuming and capital/management intensive.
  • Clinical operating system (Intangible assets): standardized treatment protocols, documentation rigor, and care management workflows create a durable capability set that supports billing integrity and continuity of care.
  • Referral and payer network relationships (Operational switching friction): sustained relationships with referral sources and payer-adjacent stakeholders can reduce patient acquisition volatility compared with smaller competitors.

Competitive benchmarking (industry peers):

  • Acadia Healthcare (ACHC): broader behavioral health platform with more geographic and program breadth across inpatient/residential services.
  • Universal Health Services (UHS): diversified healthcare provider with significant behavioral health operations alongside other healthcare segments.
  • LifeStance Health (LHS): strong presence in outpatient mental health delivery, competing on provider network and clinic expansion rather than primarily on inpatient/residential scale.

Pennant Group’s positioning emphasizes operating behavioral health programs with a focus on delivering care through an execution framework that supports utilization conversion and compliance, rather than competing primarily on single-modality outpatient clinic density.

πŸš€ Multi-Year Growth Drivers

  • Structural demand tailwinds for behavioral health: increased recognition of mental health conditions, broader access initiatives, and ongoing emphasis on parity for behavioral health coverage support long-run utilization.
  • Shift toward continuum-based care: growth opportunities arise when providers can manage patient transitions across levels of care, improving outcomes and reducing avoidable readmissions.
  • Capacity expansion backed by regulatory capability: scaling licensed programs requires operational maturity; providers that can add capacity while maintaining compliance and documentation quality are positioned to grow share.
  • Value-based care alignment: where payers incentivize outcomes and appropriate utilization, operational discipline in clinical pathways can support sustainable economics.

⚠ Risk Factors to Monitor

  • Reimbursement and authorization pressure: payer rate actions, increased utilization management, and claim denials can impair net revenue without a matching operational response.
  • Regulatory and compliance scrutiny: behavioral health is subject to heightened oversight related to documentation, coding, medical necessity, and patient safety. Investigations and settlements can be financially material.
  • Workforce constraints: recruiting and retaining clinicians is a recurring operational risk; staffing shortages can pressure throughput and increase labor costs.
  • Liability and reputational risk: patient outcomes, clinical incidents, and quality metrics can affect renewals, referrals, and insurer confidence.
  • Concentration of payer mix: heavy reliance on government and managed Medicaid dynamics increases exposure to policy changes.

πŸ“Š Valuation & Market View

Markets typically value behavioral health providers on enterprise value relative to operating earnings and cash generation, with primary attention to operating leverage, utilization, and reimbursement economics. Key valuation drivers include:

  • Margin sustainability: labor efficiency and net realization trends determine how much revenue translates into earnings.
  • Utilization/throughput metrics: steady, defensible volume supports the earnings base and reduces volatility.
  • Quality and compliance posture: the market discounts providers with elevated compliance risk through lower multiples and higher perceived downside.

Because this sector is operationally driven, valuation is also sensitive to incremental improvements in care delivery economics rather than product innovation alone.

πŸ” Investment Takeaway

Pennant Group can be viewed as a behavioral health operator with a defensible capability set built around regulatory-compliance execution, clinical operating discipline, and continuity of care that supports utilization conversion. Over a multi-year horizon, demand growth in behavioral health and opportunities from scaling compliant capacity can support earnings power, while outcomes will remain highly sensitive to reimbursement economics, staffing stability, and compliance risk management.


⚠ AI-generated β€” informational only. Validate using filings before investing.

πŸ“° Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for PNTG.

globenewswire.comβ€’2026-07-28

Pennant Announces Second Quarter 2026 Earnings Release and Call

EAGLE, Idaho, July 28, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter 2026 financial results on Wednesday, August 5, 2026. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Thursday, August 6, 2026, at 10:00 a.m.

zacks.comβ€’2026-07-02

The Pennant Group, Inc. (PNTG) Soars to 52-Week High, Time to Cash Out?

The Pennant Group (PNTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

zacks.comβ€’2026-06-24

DaVita Stock Benefits From Expanding Community-Based Kidney Care

DVA is expanding kidney care through outpatient, home-centered and value-based programs while investing in AI-enabled scheduling.

zacks.comβ€’2026-06-04

Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now

The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.

globenewswire.comβ€’2026-06-04

The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut

EAGLE, Idaho, June 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care, and senior living companies, and Hartford HealthCare, a leading integrated health system serving Connecticut, announced the next evolution of their strategic collaboration to strengthen and expand home-based care services across Connecticut.

globenewswire.comβ€’2026-06-03

Pennant Expands Senior Living Presence with Pleasant Hill, California Community

EAGLE, Idaho, June 03, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it assumed operations of a senior living community in Pleasant Hill, California, known as Memory Care of Contra Costa, on Monday, June 1. This acquisition marks Pennant's first senior living expansion into California since becoming an independent publicly traded company in 2019.

zacks.comβ€’2026-06-02

Wall Street Analysts Believe The Pennant Group (PNTG) Could Rally 27.59%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.comβ€’2026-06-01

The Pennant Group (PNTG) Upgraded to Buy: What Does It Mean for the Stock?

The Pennant Group (PNTG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.comβ€’2026-05-26

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.

globenewswire.comβ€’2026-05-18

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference

EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 RBC Global Healthcare Conference on May 20, 2026. John Gochnour, President and Chief Operating Officer, Lynette Walbom, Chief Financial Officer, and Andy Rider, President of Senior Living, will participate in a fireside chat on May 20, 2026 at 9:30 a.m. Eastern Time. A live webcast of the event will be accessible at https://kvgo.com/rbc/the-pennant-group-inc-may-2026.

globenewswire.comβ€’2026-05-18

Pennant Announces an Acquisition of Senior Living Community in Arizona

EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community, Copper Canyon Memory Care in Tucson, Arizona.

globenewswire.comβ€’2026-05-18

Pennant Announces an Acquisition of Senior Living Community in Arizona

EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community, Copper Canyon Memory Care in Tucson, Arizona. The newly acquired community offers memory care services and increases Pennant's Arizona operations by 40 units.

zacks.comβ€’2026-05-18

3 Reasons Why Growth Investors Shouldn't Overlook The Pennant Group (PNTG)

The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.

marketbeat.comβ€’2026-05-08

The Pennant Group Q1 Earnings Call Highlights

The Pennant Group NASDAQ: PNTG reported a sharp increase in first-quarter 2026 revenue and adjusted earnings as growth in its home health and hospice business, continued senior living margin improvement and ongoing integration of newly added operations helped drive results.

seekingalpha.comβ€’2026-05-07

The Pennant Group, Inc. (PNTG) Q1 2026 Earnings Call Transcript

The Pennant Group, Inc. (PNTG) Q1 2026 Earnings Call Transcript

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"PNTG reported Q1 2026 revenue of $285.4M and net income of $8.5M (EPS $0.25). Revenue rose 36.0% YoY ($285.4M vs. $209.8M) and fell 1.4% QoQ ($285.4M vs. $289.3M). Net income increased 9.6% YoY ($8.5M vs. $7.8M) but declined 1.4% QoQ ($8.5M vs. $8.6M). Profitability was pressured modestly on a quarterly basis: net margin was ~2.99% in Q1 2026 versus ~2.99% in Q4 2025 (flat), and improved vs. Q1 2025 (~3.71%) only on a point-in-time basis despite the larger sales run-rate. Operating income was $17.3M with an operating margin of ~6.06%β€”slightly below Q4 2025 (~6.25%) but broadly consistent. Cash flow quality weakened sharply in Q1: operating cash flow was -$3.4M and free cash flow was -$8.7M, versus positive operating cash flow in Q4 2025 ($21.0M). Balance sheet leverage remained high (total debt ~$446.5M; net debt ~$441.6M) but equity grew QoQ (total stockholders’ equity $389M vs. $374M). Shareholder returns appear positive given marketPerformance (price up 17.33% over 1Y), though buybacks/dividends are absent in the provided cash flow. Analyst targets ($39 consensus) sit above the current context price ($30.74), suggesting upside."

Revenue Growth

Good

Revenue grew 36.0% YoY in Q1 2026 ($285.4M vs. $209.8M) but was slightly down 1.4% QoQ ($289.3M in Q4 2025 to $285.4M).

Profitability

Neutral

Net income grew 9.6% YoY to $8.5M but declined 1.4% QoQ. Net margin was ~3.0% in Q1 2026 vs ~2.99% in Q4 2025 (flat) and below Q1 2025 (~3.71%), indicating mild profitability dilution from the revenue surge.

Cash Flow Quality

Caution

Q1 2026 operating cash flow was -$3.4M and free cash flow was -$8.7M, a sharp deterioration vs Q4 2025 (OCF +$21.0M; FCF +$14.0M). No dividends and no repurchases shown.

Leverage & Balance Sheet

Fair

Leverage remains elevated: total debt ~ $446.5M and net debt ~ $441.6M. However, equity strengthened QoQ (total stockholders’ equity $389.4M vs. $374.3M), offering some resilience.

Shareholder Returns

Neutral

Price is up 17.33% over 1Y (positive momentum but below the >20% threshold). Cash flow shows no dividends and no buybacks in the quarter, limiting visible shareholder yield.

Analyst Sentiment & Valuation

Positive

Consensus target is $39 vs current price $30.74, implying potential upside. Valuation metrics provided (e.g., P/E ~31) suggest the market is pricing meaningful future performance.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Pennant reported strong Q1’26 growth with revenue up 36% to $285.4M and adjusted diluted EPS up 18.5% to $0.32. The key operating story is margin split: same-store Home Health adjusted EBITDA margin prior to NCI rose to 17.2% (+110 bps YoY), but total segment margin fell to 15.5% (-70 bps) from expected transition-services agreement costs and system integration of 50+ new operations. Senior Living was a bright spot, with adjusted EBITDA margin expanding to 11.8% (+190 bps) alongside occupancy improvement. Southeast EMR/system integration from UnitedHealthcare is advancing (2 of 5 waves complete; wave 3 begun), with management forecasting TS expense roll-off over Q2–early Q3 and winding down by September/October. Hospice has a tangible regulatory catalyst: the proposed 2026 hospice rule implies a +2.4% daily rate increase expected to help in Q4. Risks remain concentrated in wage pressure, reimbursement headwinds, CAP/competition variability, and transitional census volatility.

AI IconGrowth Catalysts

  • Home Health & Hospice admissions growth: total admissions +62.7%, Medicare admissions +75.1%; same-store Medicare admissions +9.2%
  • Hospice momentum: average daily census +37%; same-store hospice ADC +10.2% with discharge length of stay decreasing
  • Same-store Home Health adjusted EBITDA margin prior to NCI improving to 17.2% (+110 bps YoY)
  • Senior Living margin expansion: segment adjusted EBITDA margin to 11.8% (+190 bps YoY) on occupancy gains (same-store occupancy +180 bps)

Business Development

  • Transition of Southeast Home Health/Hospice operations from UnitedHealthcare: progressed 2 of 5 integration waves; expected completion through October
  • Potential joint ventures with integrated health care systems (management: using a 6-year track record with premier systems)
  • Senior Living acquisitions: Lavender Lane Senior Living (acquired April 1, 2026; 43 assisted/memory care + 25 independent living) and triple-net leased communities added May 1, 2026 (Glendale AZ 100-unit β€œSaguaro Senior Living”; Wisconsin β€œCardinal Lane Senior Living” 45 units; β€œHarbor Haven Senior Living” 50 units)

AI IconFinancial Highlights

  • Revenue: $285.4M, +$75.5M (+36%) YoY
  • Adjusted diluted EPS: $0.32, +$0.05 (+18.5%) YoY; GAAP diluted EPS $0.24, +$0.02 (+9.1%)
  • Segment margins: same-store Home Health adjusted EBITDA margin prior to NCI 17.2% (+110 bps YoY); total segment adjusted EBITDA margin prior to NCI declined to 15.5% (-70 bps) due to >50 new operations transitioning and higher transition-services-agreement costs
  • Senior Living margin: adjusted EBITDA margin improved to 11.8% (+190 bps YoY)
  • Hospice regulatory tailwind: proposed 2026 hospice rule in April includes a +2.4% hospice daily rate increase (expected tailwind in Q4)
  • Headwinds acknowledged: 1.3% reduction in Medicare Home Health base rate; labor wage pressure; expected EMR transition census disruption with rebound

AI IconCapital Funding

  • Credit facility usage at quarter end: $72.0M revolver outstanding; $98.8M term loan outstanding (total $170.8M)
  • Cash on hand: $4.9M at quarter end
  • Leverage: net debt to adjusted EBITDA 1.93x
  • Cash flow: cash used in operations $3.4M (improved $17.8M vs prior year quarter)

AI IconStrategy & Ops

  • EMR/system integration: Tennessee/Alabama/Georgia transition from UnitedHealthcareβ€”moved 2 of 5 waves fully into systems; began 3rd wave; management expects completion by end of Q3 and continued work through October
  • Margin roll-off expectations: management expects transition-services agreement costs to roll off as agencies enter systems, with margin improvement built into guidance not immediate or perfectly linear
  • Senior Living capex/integration pattern: management indicated heavier CapEx spend in early year due to end-Q4 acquisitions; CapEx outlook guided to ~$15M–$18M for 2026
  • Census volatility management: rebounded to above acquisition levels despite EMR transition, holiday seasonality, and January severe weather

AI IconMarket Outlook

  • No guidance adjustment; management stated results are positioned toward the upper end of the guidance range
  • Transition cadence expectation: bulk of transition heavy lifting in Q2 through early Q3; September/October β€œwinding down” and TS expenses dropping
  • Hospice: +2.4% hospice daily rate increase expected to provide additional tailwind in Q4

AI IconRisks & Headwinds

  • EMR transition disruption risk: modest census blips expected during transition; January weather reduced admissions but rebounded afterward
  • Medicare reimbursement and labor: 1.3% reduction in Medicare Home Health base rate; continued wage pressure
  • Margin dilution during ramp: -70 bps total segment margin prior to NCI to 15.5% due to transitioning >50 new operations and higher transition-services-agreement costs
  • CAP (care-at-capacity) constraints and competition: California and other higher-reimbursement markets may face short-stay competition that can pressure CAP; local outreach and patient appropriateness required to mitigate
  • Fuel cost variability: management expects short-term flux and does not build significant fuel expense/mileage increases into current guidance; monitoring stipends/mileage adjustments if needed
  • Fraud/waste/abuse enforcement: administration focus could create blunt tools; management highlighted ongoing compliance audits per provider number and believes enforcement can reopen opportunities for well-performing, compliant agencies

Q&A: Analyst Interest

  • Integration cadence/margin impact: Management described progress through 2 of 5 Southeast waves and starting wave 3, emphasizing leadership development placement (CEO/CIT programs) and KPI rebound after completed agencies. They indicated margin is β€œright on target” but transition-services agreement costs roll off over the year.
  • Hospice operational dynamics (ADC vs admissions, CAP, fuel): Management cited same-store hospice ADC +10.2% with discharge length of stay decreasing and improved referral education to bring patients on hospice earlier. They noted CAP pressures as local and California-like higher reimbursement markets can limit days; fuel risk viewed as short-term.
  • Joint venture receptivity with hospitals and transition timing: Management said they have six years’ experience partnering with premier integrated systems and can decamp underperforming hospital components and reduce readmissions/acute returns. For integration, they guided bulk transition through Q2 and early Q3, then winding down in September/October as TS expenses drop.

Sentiment: MIXED

Note: This summary was synthesized by AI from the PNTG Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

πŸ“‹ Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for PNTG.

SEC EDGAR Live Feed
Loading financial data and tables...
πŸ“

SEC Filings (PNTG)

Β© 2026 Stock Market Info β€” The Pennant Group, Inc. (PNTG) Financial Profile